跳至主要内容
临床试验/NL-OMON27359
NL-OMON27359招募中不适用

Iron overload in MDS patients: The value of new iron parameters and MRI T2* of heart and liver as predictor of iron overload.

niversity Medical Centre NIjmegenDepartmetn of Hematology0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
75

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients with MDS according to WHO 2001-criteria (RA, RARS, RAEB-1, RAEB-2, RCMD, RCMD-RS, MDS with isolated del(5q), MDS-U);
  • 2. Patient with IPSS low-risk, intermediate-1 or intermediate-2 risk;

排除标准

  • 1. Patients with previous intensive anti-leukemic therapy (intensive chemotherapy and/or stem cell transplantation);
  • 2. Patients with secondary or therapy-related AML and MDS after chemotherapy for a malignancy or radiotherapy;

研究者

发起方
niversity Medical Centre NIjmegenDepartmetn of Hematology

相似试验